নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

chanelle pharmaceuticals manufacturing ltd - toltrazuril - mikstur, suspensjon - 50 mg/ ml

নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

animedica gmbh - r-kloprostenolnatrium - injeksjonsvæske, oppløsning - 75 mikrog/ ml

নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

elanco gmbh - milbemycinoksim / prazikvantel - tablett - 2.5 mg / 25 mg

নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

elanco gmbh - milbemycinoksim / prazikvantel - tablett - 12.5 mg / 125 mg

ইউরোপীয় ইউনিয়ন - নরওয়েজীয় - EMA (European Medicines Agency)

pinax pharma gmbh - ioflupane (123i) - radionuclide imaging; dementia; movement disorders - diagnostiske radiopharmaceuticals - dette legemidlet er kun til diagnostisk bruk. celsunax is indicated for detecting loss of functional dopaminergic neuron terminals in the striatum:in adult patients with clinically uncertain parkinsonian syndromes, for example those with early symptoms, in order to help differentiate essential tremor from parkinsonian syndromes related to idiopathic parkinson’s disease, multiple system atrophy and progressive supranuclear palsy.  celsunax is unable to discriminate between parkinson's disease, multiple system atrophy and progressive supranuclear palsy. hos voksne pasienter, for å kunne skille mellom sannsynlig demens med lewy legemer fra alzheimers sykdom.  celsunax is unable to discriminate between dementia with lewy bodies and parkinson’s disease dementia.

ইউরোপীয় ইউনিয়ন - নরওয়েজীয় - EMA (European Medicines Agency)

teva pharma b.v. - budesonide, formoterol - astma - legemidler for obstruktive sykdommer i luftveiene, - budesonid / formoterol teva pharma b. er angitt hos voksne 18 år og eldre. asthmabudesonide/formoterol teva pharma b. is indicated in the regular treatment of asthma, where use of a combination (inhaled corticosteroid and long-acting β2 adrenoceptor agonist) is appropriate: orin patients not adequately controlled with inhaled corticosteroids and “as needed” inhaled short-acting β2 adrenoceptor agonists. in patients already adequately controlled on both inhaled corticosteroids and long-acting β2 adrenoceptor agonists.

নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

bayer animal health gmbh - toltrazuril - mikstur, suspensjon - 50 mg/ ml

ইউরোপীয় ইউনিয়ন - নরওয়েজীয় - EMA (European Medicines Agency)

taw pharma (ireland) limited - klopidogrelhydroklorid - peripheral vascular diseases; stroke; myocardial infarction; acute coronary syndrome - antithrombotic agents - , , , , secondary prevention of atherothrombotic events, , clopidogrel is indicated in: , - adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease. , - adult patients suffering from acute coronary syndrome:,    - non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa). ,     - st segment elevation acute myocardial infarction, in combination with asa in medically treated patients eligible for thrombolytic therapy. , , in patients with moderate to high-risk transient ischaemic attack (tia) or minor ischaemic stroke (is), clopidogrel in combination with asa is indicated in:, - adult patients with moderate to high-risk tia (abcd2  score ≥4) or minor is (nihss  ≤3) within 24 hours of either the tia or is event.  , , prevention of atherothrombotic and thromboembolic events in atrial fibrillation, in adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for treatment with vitamin k antagonists (vka) and who have a low bleeding risk, clopidogrel is indicated in combination with asa for the prevention of atherothrombotic and thromboembolic events, including stroke. , , for further information please refer to section 5. , , ,.

ইউরোপীয় ইউনিয়ন - নরওয়েজীয় - EMA (European Medicines Agency)

sandoz gmbh - pregabalin - anxiety disorders; epilepsy - antiepileptics, - epilepsypregabalin sandoz gmbh er indisert som tilleggsbehandling hos voksne med partielle anfall med eller uten sekundær generalisering. generell angst disorderpregabalin sandoz gmbh er angitt for behandling av generalisert angstlidelse (gad) i voksne.

নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

bayer animal health gmbh - toltrazuril - mikstur, suspensjon - 50 mg/ ml